Patterns Identified With Cerebral Venous Thrombosis in a Population-Based Study
Researchers sought to determine patters related to age and sex in outcomes for patients with CVT.
Diagnosis & Disease Information
D-Dimer Levels Have Limited Value in Identifying Pulmonary Embolism in COVID-19
Researchers explored the use of D-dimer levels to rule out PTE in patients with COVID-19, as well as clinical associations between D-dimer levels and PTE.
Venous Thromboembolism Increasing in Inflammatory Bowel Disease Hospitalizations
Researchers assessed nationwide trends of venous thromboembolism-related hospitalizations among patients with inflammatory bowel disease.
Vaccination Status May Affect Venous Thromboembolism Risk in Ambulatory COVID-19
Researchers assessed the 30-day risk for VTE among ambulatory patients with COVID-19 and compared, via propensity-score matching, individuals without COVID-19 infection.
Outcomes May Be Better for Warfarin Users Who Stop Aspirin Use
Quality improvement effort tied to decrease in major bleeding without increase in thrombotic events.
OAC in Patients With AF and COVID-19 Lowers Rates of Death, Thrombotic Events
Researchers assessed the relationship between oral anticoagulation for patients with COVID-19 and AF and incidence of in-hospital thrombotic events and death.
Recommendations Issued for Perioperative Antithrombotic Management
Two strong recommendations developed against use of heparin bridging in a-fib, and for continuation of VKA in patients getting pacemaker/ICD.
Variable Dose Thromboprophylaxis May Increase Survival in Patients With COVID-19
Researched compared standard vs variable thromboprophylaxis strategies on the risk of mortality among patients hospitalized with COVID-19.
DOACs May Be a Viable Alternative to LMWH in Venous Thromboembolism
Researcher sought to determine whether DOACs would be an alternative to low molecular weight heparin in patients with lymphoma or plasma cell dyscrasia with VTE.
Can Pulmonary Embolism Severity Indices Predict COVID-19-Related Adverse Events?
Can the pulmonary embolism severity index assess the risk for adverse events among patients hospitalized for COVID-19 who are not diagnosed with PE or VTE?
- Loading...
Loading...
Next post in Thrombotic Disorders
Loading... 
Loading...